Fatores cardiometabólicos relacionados a condições pós Covid-19: scoping review

João  Cruz Neto; Vinícius Fiuza Carlos   Olivindo; José Arthur Guimarães dos Santos; Kadson Araujo da Silva; Romulo de Oliveira Sales  Junior

doi:10.15649/cuidarte.4290

Authors

João Cruz Neto Universidade Federal do Ceará – UFC. Fortaleza, Ceará, Brazil. https://orcid.org/0000-0002-0972-2988
Carlos Vinícius Fiuza Olivindo Universidade Federal do Ceará – UFC. Fortaleza, Ceará, Brazil. https://orcid.org/0009-0009-3061-0073
José Arthur Guimarães dos Santos Universidade Federal da Paraíba - UFPB. João Pessoal, Paraíba, Brazil. https://orcid.org/0000-0002-8451-8055
Kadson Araujo da Silva Universidade Federal do Ceará – UFC. Fortaleza, Ceará, Brazil. https://orcid.org/0000-0001-6397-0686
Romulo de Oliveira Sales Junior Universidade Estadual Paulista - UNESP. São Paulo, Brazil. https://orcid.org/0000-0002-4638-7971

DOI:

https://doi.org/10.15649/cuidarte.4290

Keywords:

Adult, COVID-19, Syndrome, Cardiometabolic Risk Factors

Abstract

Highlights

Post-COVID-19 syndrome is a pathology with several physical and psychosocial consequences.
Early identification of cardiometabolic risk factors improves the prevention of complications in the clinical picture.
The findings highlight the importance of the health system in preventing SARS-CoV-2 infection from progressing to serious illness.
Changes in therapeutic, diagnostic and prognostic standards related to Covid-19 remain a challenge in health care.

Introduction: Post-COVID syndrome is a pathology that involves multiple sequelae. It is important to identify cardiometabolic risk factors as a way of preventing complications. Objective: To map the scientific evidence related to cardiometabolic factors in long post-COVID-19 conditions. Materials and Methods: Scoping review with the guiding question: What scientific evidence relates cardiometabolic factors to patients with long post-Covid-19 syndrome? The sources of information used were six databases via the CAPES journal portal. For the gray literature, we used the CAPES catalog of theses and dissertations, the Brazilian Digital Library of Theses and Dissertations, the Who Library Database and the medRxiv and OpenGrey repositories. The following descriptors were used: Adult, heart disease risk factors, Syndrome, SARS-CoV-2 and Covid 19 crossed using the Boolean operators AND and OR. Results: 14 studies were included. The cardiometabolic factors found were: abnormal levels of triglycerides, glycated hemoglobin, ferritin, inflammatory processes, decreased platelets, phospholipids and endothelial cells, oxidative stress, higher concentrations of monosaccharides and reduced polysaccharides, increased LDL, ALT, AST and bilirubin, with reduced GFR. Discussion: Patients with long-term COVID report persistent and debilitating symptoms that affect recovery, quality of life, economic and social activities. In addition to increased resting heart rate, tachycardia, palpitations, hypotension, syncope, orthostatic tachycardia, angina and heart attack. Conclusions: Cardiometabolic factors expose the vulnerability of individuals affected by long Covid-19, so strategies are needed to reduce the systemic inflammatory impact of the disease and its clinical consequences.

How to cite this article: Cruz Neto, João; Olivindo, Vinícius Fiuza Carlos; Santos, José Arthur Guimarães dos; Silva, Kadson Araujo da; Junior, Romulo de Oliveira Sales. Cardiometabolic factors related to post-COVID-19 conditions: scoping review. Revista Cuidarte. 2025;16(2):e4290. https://doi.org/10.15649/cuidarte.4920

Author Biographies

João Cruz Neto, Universidade Federal do Ceará – UFC. Fortaleza, Ceará, Brazil.

Enfermeiro, mestre em enfermagem pela Universidade da Integração Internacional da Lusofonia Afro-Brasileira.
Carlos Vinícius Fiuza Olivindo, Universidade Federal do Ceará – UFC. Fortaleza, Ceará, Brazil.

Universidade Federal do Ceará – UFC. Fortaleza, Ceará, Brasil.
José Arthur Guimarães dos Santos, Universidade Federal da Paraíba - UFPB. João Pessoal, Paraíba, Brazil.

Enfermeiro. Mestrando do Programa de Pós-Graduação em Enfermagem (PPGENF/UFPB). Especialista em Atenção Cardiovascular pela modalidade de Residência (HUNE/FACENE).
Kadson Araujo da Silva, Universidade Federal do Ceará – UFC. Fortaleza, Ceará, Brazil.

Universidade Federal do Ceará – UFC. Fortaleza, Ceará, Brasil.
Romulo de Oliveira Sales Junior, Universidade Estadual Paulista - UNESP. São Paulo, Brazil.

Odontólogo. Mestre em Ciências Odontológicas pela Universidade Estadual Paulista Júlio de Mesquita Filho - UNESP.

References

Mechanick JI, Farkouh ME, Newman JD, Garvey WT. Cardiometabolic-Based Chronic Disease, Addressing Knowledge and Clinical Practice Gaps. J Am Coll Cardiol 2020;75(5):539–55. https://doi.org/10.1016/j.jacc.2019.11.046

Norris T, Razieh C, Zaccardi F, Yates T, Islam N, Gillies CL, et al. Impact of cardiometabolic multimorbidity and ethnicity on cardiovascular/renal complications in patients with COVID-19. Heart. 2022;108(15):1200-1208. https://doi.org/10.1136/heartjnl-2021-320047

Bansal R, Gubbi S, Muniyappa R. Metabolic syndrome and COVID 19: Endocrine-immune-vascular interactions shapes clinical course. Endocrinology. 2020:161(10):1-15. https://doi.org/10.1210/endocr/bqaa112

Melo FH de, Melo LHL. Complicações cardiovasculares pós-COVID-19. Revista Eletrônica Acervo Médico. 2023;23(1):e11726. https://doi.org/10.25248/reamed.e11726.2023

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet [Internet]. 2020;395(10229):1054–62. https://doi.org/10.1016/S0140-6736(20)30566-3

Ministério da Saúde. Nota técnica No 62/2021-SECOVID/GAB/SECOVID/MS. Brasil. 2021. Consulta: 09 março, 2023. Disponível em: https://www.cosemssp.org.br/wp-content/uploads/2021/11/SEI_MS-0023992174-Nota-Tecnica-62-Anexo-Oficio-Circular-101.pdf

World Health Organization. Emergency use ICD codes for COVID-19 disease outbreak. [Internet] 2023 [Cited 2023 march 9] Available from: https://www.who.int/standards/classifications/classification-of-diseases/emergency-use-icd-codes-for-covid-19-disease-outbreak

Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis [Internet]. 2021;53(10):737–54. https://doi.org/10.1080/23744235.2021.1924397

Fernández-de-las-Peñas C, Palacios-Ceña D, Gómez-Mayordomo V, Florencio LL, Cuadrado ML, Plaza-Manzano G, et al. Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis. Eur J Intern Med. 2021;92:55–70. https://doi.org/10.1016/j.ejim.2021.06.009

Oronsky B, Larson C, Hammond TC, Oronsky A, Kesari S, Lybeck M, et al. A Review of Persistent Post-COVID Syndrome (PPCS). Clin rev allergy immunol. 2023; 64(1): 66–74. https://doi.org/10.1007/s12016-021-08848-3

Cruz Neto J, Frota Cavalcante T, de Carvalho Félix ND. Post-COVID-19 metabolic syndrome: a new challenge for nursing care. Invest Educ Enferm. 2023;41(1):01-04. https://doi.org/10.17533/udea.iee.v41n1e01

Peters M, Godfrey C, McInerney P, Munn Z, Trico A, Khalil H. Chapter 11: Scoping Reviews. In: JBI Manual for Evidence Synthesis. JBI; 2020. http://dx.doi.org/10.46658/JBIMES-20-12

McGowan J, Straus S, Moher D, Langlois EV, O’Brien KK, Horsley T, et al. Reporting scoping reviews—PRISMA ScR extension. Journal of Clinical Epidemiology. 2020; 123:177–9. https://doi.org/10.1016/j.jclinepi.2020.03.016

Silva KA, Cruz Neto, J. “Cardiometabolic factors related to post-COVID-19 conditions: a scoping review”, Mendeley Data, v1, 2024. https://doi.org/10.17632/v2xwy689mn.1

McKeown S, Mir ZM. Considerations for conducting systematic reviews: evaluating the performance of different methods for de-duplicating references. Syst Rev. 2021;110(1): 38. https://doi.org/10.1186/s13643-021-01583-y

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement. J Clin Epidemiol. 2021;134:103–12. https://doi.org/10.1016/j.jclinepi.2021.02.003

Menezes DC de, Lima PDL de, Lima IC de, Uesugi JHE, Vasconcelos PF da C, Quaresma JAS, et al. Metabolic Profile of Patients with Long COVID: A Cross-Sectional Study. Nutrients. 2023;15(5):1197. https://doi.org/10.3390/nu15051197

Chudzik M, Lewek J, Kapusta J, Banach M, Jankowski P, Bielecka-Dabrowa A. Predictors of Long COVID in Patients without Comorbidities: Data from the Polish Long-COVID Cardiovascular (PoLoCOV-CVD) Study. J Clin Med. 2022;11(17):4980. https://doi.org/10.3390/jcm11174980

Oliveira CAF de. Resposta inflamatória e risco de sarcopenia após infecção por COVID-19 em pacientes diabéticos renais crônicos com sobrepeso/obesidade, em hemodiálise. Dissertação (mestrado em ciências médicas) - Universidade Federal de Alagoas, 2022. http://www.repositorio.ufal.br/jspui/handle/123456789/11037

Fierro P, Martín D, Pariente E, García-Garrido AB, Basterrechea H, Petitta B, Et al. Post-COVID-19 syndrome and insulin resistance 20 months after a mild COVID-19. Ascensión Jorrín. 2023;(1):33. https://doi.org/10.1101/2023.04.17.23288637

Sahanic S, Tymoszuk P, Ausserhofer D, Rass V, Pizzini A, Nordmeyer G, et al. Phenotyping of Acute and Persistent Coronavirus Disease 2019 Features in the Outpatient Setting: Exploratory Analysis of an International Cross-sectional Online Survey. Clinical Infectious Diseases. 2022;75(1):418–31. https://doi.org/10.1093/cid/ciab978

Gaudet LA, Pillay J, Saba S, Zakaria D, Cheta N, Gardiner H, et al. Associations between SARS-CoV-2 infection and incidence of new chronic condition diagnoses: a systematic review. Emerging Microbes and Infections. 2023;12(1):2204166. https://doi.org/10.1080/22221751.2023.2204166

Barh D, Tiwari S, Andrade BS, Weener ME, Góes-Neto A, Azevedo V, et al. A novel multi-omics-based highly accurate prediction of symptoms, comorbid conditions, and possible long-term complications of COVID-19. Mol Omics. 2021;17(2):317–37. https://doi.org/10.1039/d0mo00189a

Rezel-Potts E, Douiri A, Sun X, Chowienczyk PJ, Shah AM, Gulliford MC. Cardiometabolic outcomes up to 12 months after COVID-19 infection. A matched cohort study in the UK. PLoS Med. 2022;19(7):e1004052. https://doi.org/10.1371/journal.pmed.1004052

Wiemken TL, McGrath LJ, Andersen KM, Khan F, Malhotra D, Alfred T, et al. Coronavirus Disease 2019 Severity and Risk of Subsequent Cardiovascular Events. Clinical Infectious Diseases. 2023;76(3):42–50. https://doi.org/10.1093/cid/ciac661

Radaeva OA, Balykova LA, Zaslavskaya KY, Taganov A V, Bely PA, Kostina YA, et al. Study of long-term clinical and pathogenetic effects of favipiravir-based anti-viral drug in patients with metabolic syndrome in post-covid period. Farmatsiya i Farmakologiya. 2022;10(2):217–28. https://doi.org/10.19163/2307-9266-2022-10-2-217-228

Guo B, Zhao C, He MZ, Senter C, Zhou Z, Peng J, et al. Identifying patterns of reported findings on long-term cardiac complications of COVID-19: a systematic review and meta-analysis. BMC Medicine. 2023;21(468):01-12. https://doi.org/10.1186/s12916-023-03162-5

Cheng D, Calderwood C, Skyllberg E, Ainley A. Clinical characteristics and outcomes of adult patients admitted with COVID-19 in East London: A retrospective cohort analysis. BMJ Open Respir Res. 2021;8(1):e000813.https://doi.org/10.1136/bmjresp-2020-000813

Roessler M, Tesch F, Batram M, Jacob J, Loser F, Weidinger O, et al. Post-COVID-19-associated morbidity in children, adolescents, and adults: A matched cohort study including more than 157,000 individuals with COVID-19 in Germany. PLoS Med. 2022; 19(11):e1004122. https://doi.org/10.1371/journal.pmed.1004122

Österdahl MF, Whiston R, Sudre CH, Asnicar F, Cheetham NJ, Blanco Miguez A, et al. Metabolomic and gut microbiome profiles across the spectrum of community-based COVID and non-COVID disease. Sci Rep. 2023;13(1):10407.https://doi.org/10.1038/s41598-023-34598-7

Ely EW, Brown LM, Fineberg HV. Long Covid defined. N Engl J Med. 2024;391(18):1–8. https://doi.org/10.1056/NEJMsb2408466

Lai CC, Hsu CK, Yen MY, Lee PI, Ko WC, Hsueh PR. Long COVID: An inevitable sequela of SARS-CoV-2 infection. Journal of Microbiology, Immunology and Infection. 2023;56(1):1-9. https://doi.org/10.1016/j.jmii.2022.10.003

Gangitano E, Tozzi R, Gandini O, Watanabe M, Basciani S, Mariani S, et al. Ketogenic diet as a preventive and supportive care for covid-19 patients. Nutrients. 2021; 13(3):1004. https://doi.org/10.3390/nu13031004

Scherer PE, Kirwan JP, Rosen CJ. Post-acute sequelae of COVID-19: A metabolic perspective. eLife Sciences Publications. 2022;23:11:e78200. https://doi.org/10.7554/eLife.78200

Bornstein SR, Voit-Bak K, Donate T, Rodionov RN, Gainetdinov RR, Tselmin S, et al. Chronic post-COVID-19 syndrome and chronic fatigue syndrome: Is there a role for extracorporeal apheresis? Molecular Psychiatry. 2022;27(1):34-37. https://doi.org/10.1038/s41380-021-01148-4

Mackay A. A Paradigm for Post-Covid-19 Fatigue Syndrome Analogous to ME/CFS. Front Neurol. 2021;2(12):701419. https://doi.org/10.3389/fneur.2021.701419

Wostyn P. COVID-19 and chronic fatigue syndrome: Is the worst yet to come? Med Hypotheses. 2021;146:110469. https://doi.org/10.1016/j.mehy.2020.110469

Di Girolamo FG, Fiotti N, Sisto UG, Nunnari A, Colla S, Mearelli F, et al. Skeletal Muscle in Hypoxia and Inflammation: Insights on the COVID-19 Pandemic. Frontiers in Nutrition. 2022; 22(9):865402. https://doi.org/10.3389/fnut.2022.865402

Ashton R, Ansdell P, Hume E, Maden-Wilkinson T, Ryan D, Tuttiett E, et al. COVID-19 and the long-term cardio-respiratory and metabolic health complications. Reviews in Cardiovascular Medicine. 2022;23(2):53. https://doi.org/10.31083/j.rcm2302053

Touyz RM, Boyd MOE, Guzik T, Padmanabhan S, McCallum L, Delles C, et al. Cardiovascular and Renal Risk Factors and Complications Associated With COVID-19. CJC Open. 2021; 3(10):1257-1272. https://doi.org/10.1016/j.cjco.2021.05.020